摘要
原发性肝癌是我国最常见的恶性肿瘤之一,中医药在控制患者病情发展、改善症状体征及提高生存质量等方面的优势日渐显现。故认为正气亏虚是肝癌发病的内在基础,瘀血阻滞是肝癌发病的基本病理因素,因此益气活血治法正切合肝癌正气亏虚、瘀血凝滞的病机本质。益气健脾药与活血化瘀药配伍可攻补兼施、改善血行、固护正气、固摄癌毒,减少肝癌扩散转移。
Primary hepatic carcinoma is one of the most common malignant tumors in China. The advantages of Chinese medicine in the control of disease development,improving the symptoms and improving survival quality and other aspects are increasingly. The deficiency of qi is the internal basis and blood stasis is the basic pathological factors of liver cancer incidence. Therefore Yiqi Huoxue method conforms to pathogenesis essence of primary liver cancer. The compatibility of Yiqi and Huoxue medicine can improve blood circulation,support the healthy energy,prevent the cancer thrombus and reduce liver cancer metastasis.
出处
《中国中医基础医学杂志》
CAS
CSCD
北大核心
2015年第12期1498-1500,1521,共4页
JOURNAL OF BASIC CHINESE MEDICINE
基金
国家自然科学基金面上项目(81373990)-黄芪
莪术配伍调控肝癌血管生成的体视学及分子机制研究
国家自然科学基金青年基金项目(81503270)-基于VEGFR1/PDGFR信号通路的黄芪
莪术配伍促肿瘤新生血管正常化的机制研究
河南省教育厅高校重点科研项目(15A360011)-基于HGF/c-met信号通路的黄芪
莪术配伍调控肝癌血管生成的分子机制研究
关键词
原发性肝癌
益气活血法
病机
配伍
Primary liver cancer
Yiqi Huoxue method
Pathogenesis
Compatibility